Clinical importance of IL-22 cascade in IBD Atsushi MizoguchiArisa YanoEmiko Mizoguchi Review Open access 26 October 2017 Pages: 465 - 474
Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis Kazushige UchidaKazuichi Okazaki Review Open access 19 February 2018 Pages: 475 - 483
Esophageal motility disorders: new perspectives from high-resolution manometry and histopathology Hiroki SatoKazuya TakahashiShuji Terai Review 13 November 2017 Pages: 484 - 493
Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study Makoto NaganumaNobuo AoyamaToshifumi Hibi Original Article—Alimentary Tract Open access 04 August 2017 Pages: 494 - 506
Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet Nicola ImperatoreRaffaella TortoraAntonio Rispo Original Article—Alimentary Tract 19 August 2017 Pages: 507 - 516
Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population Yuko YamaokaYutaka SuehiroTakahiro Yamasaki Original Article—Alimentary Tract 19 August 2017 Pages: 517 - 524
Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial Atsushi NakajimaMitsunori SekiShinya Taniguchi Original Article—Alimentary Tract Open access 24 August 2017 Pages: 525 - 534
Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease Takashi ShidaKentaro AkiyamaJunichi Shoda Original Article—Liver, Pancreas, and Biliary Tract 08 August 2017 Pages: 535 - 547
Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study Yoshiiku KawakamiHidenori OchiKazuaki Chayama Original Article—Liver, Pancreas, and Biliary Tract 16 August 2017 Pages: 548 - 556
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis Kazuaki ChayamaFumitaka SuzukiHiromitsu Kumada Original Article—Liver, Pancreas, and Biliary Tract Open access 25 September 2017 Pages: 557 - 565
Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection Hiromitsu KumadaTsunamasa WatanabeKazuaki Chayama Original Article—Liver, Pancreas, and Biliary Tract Open access 20 October 2017 Pages: 566 - 575
Erratum to: Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma Wenhui WangQiuwei PanMaikel P. Peppelenbosch Erratum 11 October 2017 Pages: 576 - 577
Erratum to: Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet Nicola ImperatoreRaffaella TortoraAntonio Rispo Erratum 19 September 2017 Pages: 578 - 578
Correction to: Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study Makoto NaganumaNobuo AoyamaToshifumi Hibi Correction 13 October 2017 Pages: 579 - 581
Correction to: Basophils activated via TLR signaling may contribute to pathophysiology of type 1 autoimmune pancreatitis Masato YanagawaKazushige UchidaKazuichi Okazaki Correction 26 February 2018 Pages: 582 - 583